Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with...

Peginterferon alfa-2A (40 KD) (PEGASYS) in combination with ribavirin (RBV): efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose

S.J. Hadziyannis, H. Cheinquer, T. Morgan, M. Diago, D.M. Jensen, H. Sette Jr., G. Ramadori, H.C. Bodenheimer, P. Marcellin, S.-D. Lee, P.J. Roberts, A.M. Ackrill
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Year:
2002
Language:
english
DOI:
10.1016/s0168-8278(02)80001-0
File:
PDF, 147 KB
english, 2002
Conversion to is in progress
Conversion to is failed